Wuxi Biologics to Conduct up to $300 Million Share Buyback; Stock Jumps 5%
Wuxi Biologics: mid-term report 2022
Wuxi Biologics's two raw liquid factories and one preparation factory have also obtained the GMP certification of several products of FDA in the United States and EMA in the European Union.
Wuxi, Jiangsu, September 20 / PRNewswire-FirstCall-Asianet /-- Wuxi Biologics, 2269.HK (WuXi Biologics, 2269.HK), a leading global contract research, development and production (CRDMO) company, announced today that its two biological drug solution plants and one preparation plant in Wuxi have been certified by the European Drug Administration (EMA) and the U.S. Food and Drug Administration (FDA) GMP. This time, Wuxi Biologics's No. 4 original liquid Factory (MFG4), No. 5 original liquid Factory (MFG5) and No. 2 preparation Plant (DP2) successfully passed EMA for two global customers.
WuXi Biologics (Cayman) (HKG:2269) Sheds 7.8% This Week, as Yearly Returns Fall More in Line With Earnings Growth
While WuXi Biologics (Cayman) Inc. (HKG:2269) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 29% in the last quarter. B
The Hang Seng Index closed down 1.04%, the Hang Seng Technology Index fell 2.07%. Among the top stocks today, Tencent fell 1.43%, BABA fell 3.57%, Wuxi Biologics fell 5.01%, JD.com fell 2.51%, Li Auto Inc. fell 5.05%, and Byd Company Limited rose 0.28%.
Nio, EV Shares Drop Over 1%, While Alibaba, Tech Peers Mixed: What's Weighing on Hong Kong Stocks Today
Hong Kong stocks opened mixed on Thursday morning, with the benchmark Hang Seng gaining 0.38%, while EV stocks declined. Shares of XPeng, Li Auto and Nio fell over 1%.
Alibaba, Baidu Slide Over 3% as Wall Street Horror Spreads to Hong Kong Stocks
Hong Kong shares plunged on Wednesday, taking cues from a heavy sell-off on Wall Street triggered by higher-than-expected U.S. inflation for August.
WuXi Biologics (Cayman) Inc. (HKG:2269) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
With its stock down 14% over the past month, it is easy to disregard WuXi Biologics (Cayman) (HKG:2269). But if you pay close attention, you might gather that its strong financials could mean that t
Alibaba, Nio Slip: Hong Kong Stocks Stumble as China Private Factory Survey Data Shrinks For 1st Time in 3 Months
Hong Kong stocks fell on Thursday, with the Hang Seng index losing 1.23% in opening trade. China's factory activity shrank for the first time in three months in August. The Caixin/Markit manufacturing purchasing managers' index (PMI) fell to 49.5 in August against 50.4 in July, reported Reuters.
WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility in Cranbury, New Jersey
CRANBURY, N.J., Aug. 31, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), today announced the release of its GMP phase I drug substance clinical manufactur